Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sugi Holdings Co's revenue for the
three
months ended in Feb. 2026 was $1,678 Mil.
Its revenue for the trailing twelve months (TTM) ended in Feb. 2026 was $6,724 Mil.
Sugi Holdings Co's Revenue per Share for the
three
months ended in Feb. 2026 was $9.27.
Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was $37.16.
Good Sign:
Sugi Holdings Co Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Sugi Holdings Co was 15.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 9.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Sugi Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 20.20% per year. The lowest was 5.40% per year. And the median was 8.10% per year.
Sugi Holdings Co (OTCPK:SGIPF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Sugi Holdings Co Revenue Related Terms
Sugi Holdings Co Revenue Historical Data
* Premium members only.
The historical data trend for Sugi Holdings Co's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Sugi Holdings Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sugi Holdings Co Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sugi Holdings Co's Revenue distribution charts can be found below:
* The bar in red indicates where Sugi Holdings Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,724 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sugi Holdings Co (SGIPF) has a Revenue of $6,724 Mil as of Feb. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Sugi Holdings Co and its competitors.
Is Sugi Holdings Co's Revenue too high?
Sugi Holdings Co's current Revenue is $6,724 Mil. Overall, Sugi Holdings Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's Revenue compare to competitors?
Sugi Holdings Co's Revenue of $6,724 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Sugi Holdings Co and its competitors. Sugi Holdings Co's current Revenue is $6,724 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Sugi Holdings Co (SGIPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $21.88, compared to a current price of $18.99 — trading 13.2% below its estimated fair value. The current Revenue is $6,724 Mil. Sugi Holdings Co's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Sugi Holdings Co (SGIPF), the current Revenue is $6,724 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sugi Holdings Co (SGIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be undervalued.
The current stock price of $18.99 is trading 13.2% below its estimated GF Value™ of $21.88.
GuruFocus considers Sugi Holdings Co to be Modestly Undervalued.
Key valuation signals for SGIPF:
Revenue: $6,724 Mil
GF Value™: $21.88 vs. price of $18.99 (13.2% below fair value)
No single metric tells the full story. See the SGIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
93GF Score
Get the complete analysis for SGIPF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGIPF has been successfully added to your 
